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Abstract
Background: Different indexes of regional adiposity have been proposed for identifying persons at higher risk of death.
Studies specifically assessing these indexes in large cohorts are scarce. It would also be interesting to know whether a
dietary intervention may counterbalance the adverse effects of adiposity on mortality.
Methods: We assessed the association of four different anthropometric indexes (waist-to-height ratio (WHtR), waist
circumference (WC), body mass index (BMI) and height) with all-cause mortality in 7447 participants at high cardiovascular
risk from the PREDIMED trial. Forty three percent of them were men (55 to 80 years) and 57% were women (60 to 80 years).
All of them were initially free of cardiovascular disease. The recruitment took place in 11 recruiting centers between 2003
and 2009.
Results: After adjusting for age, sex, smoking, diabetes, hypertension, intervention group, family history of coronary heart
disease, and leisure-time physical activity, WC and WHtR were found to be directly associated with a higher mortality after
4.8 years median follow-up. The multivariable-adjusted HRs for mortality of WHtR (cut-off points: 0.60, 0.65, 0.70) were 1.02
(0.78–1.34), 1.30 (0.97–1.75) and 1.55 (1.06–2.26). When we used WC (cut-off points: 100, 105 and 110 cm), the multivariable
adjusted Hazard Ratios (HRs) for mortality were 1.18 (0.88–1.59), 1.02 (0.74–1.41) and 1.57 (1.19–2.08). In all analyses, BMI
exhibited weaker associations with mortality than WC or WHtR. The direct association between WHtR and overall mortality
was consistent within each of the three intervention arms of the trial.
Conclusions: Our study adds further support to a stronger association of abdominal obesity than BMI with total mortality
among elderly subjects at high risk of cardiovascular disease. We did not find evidence to support that the PREDIMED
intervention was able to counterbalance the harmful effects of increased adiposity on total mortality.
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Introduction
The dose-response relationship between increased levels of
overweight/obesity and all-cause mortality is controversial. A
recent meta-analysis reported that overweight (defined as abody
mass index [BMI] of 25 to 30 kg/m2) was associated with
significantly lower all-cause mortality in comparison with the
normal weight category and that grade I obesity (BMI between 30
and 35) was associated with a non-significantly lower risk of
mortality [1]. Other previous meta-analyses also suggested inverse
or null associations, specially among elderly subjects [2,3]. In
contrast with these reports, there is a high biological plausibility to
expect a direct association between excess body weight and all-
cause mortality even at moderate levels of overweight. Some
potential biases may have attenuated the association. They include
insufficient adjustment for confounding by smoking, reverse
causation bias due to disease-related weight loss [4], effect
modification by age [5,6], with an attenuation of the detrimental
effects of overweight or even a reversion to beneficial effects in the
elderly [7]. In addition, studies using BMI as the single relevant
measurement of adiposity and not other aspects of body
composition such as visceral fat or fat distribution, may miss the
true dose-response curve between adiposity and all-cause mortal-
ity. Alternative measures of abdominal obesity are known to be
superior to BMI in showing a positive association with the risk of
cardiovascular disease or diabetes [8,9,10,11]. In addition, a
recent study has clearly shown significant associations between
waist circumference or other indexes of abdominal obesity and all-
cause mortality in white subjects [12]. Furthermore, recent studies
have suggested that the BMI should be refined by measuring
additional indexes of fat distribution namely waist circumference
(WC), waist-to-hip ratio (WHR) or waist-to height ratio (WHtR) to
better identify higher-risk subjects [13,14].
WC has been often used to appraise abdominal obesity, but WC
does not take differences in height into account, and subjects with
a given WC will have more abdominal fat than taller subjects with
the same WC [15]. The WHtR represents a further step because it
also takes height into account. A systematic review found mean
areas under receiving operator characteristic curves of 0.704,
0.693 and 0.671 for WHtR, WC and BMI, respectively as
predictors of diabetes or cardiovascular disease [10].
We assessed the association between several anthopometric
indexes (BMI, WC, WHtR, Height) and all-cause mortality in a
Mediterranean cohort of elderly subjects at high cardiovascular
risk included in the PREDIMED trial. The primary objective of
the PREDIMED trial was to test the effect of a Mediterranean-
style diet in primary cardiovascula prevention.
Methods
The protocol for the PREDIMED trial is available as
supporting information at www.predimed.es. We have previously
reported the design, objectives and methods of the PREDIMED
trial in a specific publication [16]. The PREDIMED study is a
multicenter, randomized, primary cardiovascular prevention trial
conducted in Spain (www.predimed.es). The final results were
reported in 2013 [17]. We randomly assigned participants to one
of three diets: a Mediterranean diet (MeDiet) supplemented with
extra-virgin olive oil, a MeDiet supplemented with mixed nuts, or
a control group (allocated to receive advice to reduce dietary fat).
All analyses were stratified by intervention group and adjusted for
potential confounding.
During the analysis (with the exception of spline models, see
below) we used the lowest group of each anthopometric index as
the reference category.
The protocol of this study was approved by the Institutional
Review Board of the University of Navarra and the Institutional
Review Board of the Hospital Clinic (Barcelona). The Data
Protection Agency is the Spanish National Agency (Agencia
Espan˜ola de Proteccio´n de Datos), name of the file: PREDIMED,
the responsible person for the file is Miguel A. Martı´nez-Gonza´lez.
The trial is registered at http://www.controlled-trials.com/
ISRCTN 35739639, and all clinical investigation have been
conducted according to the principles expressed in the Declaration
of Helsinki. Subjects who met entry requirements agreed to
participate and provided written informed consent.
Subjects
We enrolled 7,447 participants. Forty three percent of them were
men (55 to 80 years) and 57% were women (60 to 80 years). All of
them were initially free of cardiovascular disease, but at high
cardiovascular risk because they had at least three major cardiovas-
cular risk factors out of six candidate risk factors or, alternatively, they
were type 2 diabetics. The 6 candidate risk factors considered were:
overweight/obesity, hypertension, elevated low-density lipoprotein
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cholesterol, low high-density lipoprotein cholesterol, current smoking,
or family history of premature coronary heart disease. The specific
cut-off points for these factors and the exclusion criteria have been
previously described [16]. Participants can be assumed to be on stable
weights at the time of recruitment for the trial. Energy restriction was
not part of the PREDIMED nutritional intervention.
The recruitment took place in 11 recruiting centers between
2003 and 2009. Eighty-nine percent of candidate subjects who met
entry requirements agreed to participate and provided written
informed consent.
Measurements
Registered nurses who had been previously trained and certified
to implement the PREDIMED protocol directly measured weight,
height and WC of participants as previously described [16,18,19].
Height (m) and weight (kg) were measured with light clothing and
no shoes with calibrated scales and a wall-mounted stadiometer,
respectively; BMI was calculated as the weight in kilograms
divided by the square of the height in meters; WC was measured
midway between the lowest rib and the iliac crest using an
anthropometric tape; in other previous studies, the protocol for
WC measurement specified that WC should be measured at the
minimal waist (33%), midpoint (26%) and umbilicus (27%). We
selected the midpoint. However, the available evidence from a
2008 meta-analysis suggests that WC measurement protocol has
no substantial influence on the association between WC, all-cause
and CVD mortality, CVD and diabetes [20]; the WHtR was
calculated as WC divided by height, both in centimeters. Blood
pressure was measured in triplicate using a validated semiauto-
matic oscillometer with a 5-minute interval between each
measurement and the subject in a sitting position (Omron
HEM-705CP, Hoofddorp, The Netherlands). Hypertension was
defined as a systolic blood pressure $140 mm Hg, a diastolic
blood pressure $90 mm Hg, or the use of antihypertensive
therapy.
Confounders assessment
Participants underwent a baseline interview that included the
evaluation of cardiovascular risk factors and physician diagnoses of
hypertension, diabetes and hipercolesterolemia. At the same time
we gathered information about medical, socio-demographic,
anthropometric, and lifestyle variables. We used the Minnesota
validated physical activity questionnaire to assess leisure-time
physical activity [21,22], Time spent in several activities in minutes
per day was multiplied by its typical energy expenditure, expressed
in metabolic equivalent tasks (METs), then summed over all
activities to yield a METs-min/d score for each participant.
Taking into account that the relationship between leisure-time
physical activity (METs-min/d) and mortality was not linear in
our data, we used a polynomial model to adjust for METs-min/d,
adding a quadratic term to the multivariable model. The age
range in the validation studies was 18–60 years. Dietary habits
were collected through a semi-quantitative 137-item Food
Frequency Questionnaire previously validated in Spain [23].
Statistical analysis
We examined baseline characteristics of participants in each
variable of interest according to quartiles or to predefined
categories of anthropometric indexes. To compare means or
percentages of each variable across quartiles (or pre-defined
categories) of anthropometric indexes we used one-way ANOVA
and chi-squared tests, respectively.
We used Cox regression models to assess the Hazard Ratios
(HR) and their 95% confidence intervals for total mortality
according to quartiles or to pre-defined categories of each
anthropometric index.
For the multiple-adjusted model, the following potential
confounders (all of them measured at baseline) were considered:
age, sex, smoking, diabetes status, hypertensive status, intervention
group and family history of CHD.
To assess the dose-response shape between adiposity and
mortality we used restricted cubic splines models with 4 degrees
of freedom, and considered the point associated with the lowest
mortality as the reference value for each anthropometric index.
Finally, we also obtained the hazard ratios and their 95%
confidence intervals for total mortality according to defined cut-off
points of each anthropometric index. A p value ,0.05 was
considered statistically significant.
Analyses were performed using STATA version 12.1 (Stata-
Corp, College Station, TX, USA).
Results
Table 1 shows baseline characteristics of the 7447 participants
of PREDIMED according to quartiles (or pre-defined categories)
of anthropometric indexes. We studied baseline characteristics by
four variables of interest: WHtR, WC, BMI and height. Baseline
risk factors (hypertension, overweight, type-2-diabetes) increased
across increasing quartiles, as expected, with the exceptions of
dyslipidemia and family history of premature CHD, that
decreased with increasing quartiles. We also observed that
adherence to the MeDiet tended to decrease across increasing
quartiles of anthropometric indexes. Leisure-time physical activity
followed the same inverse trend across adiposity indexes, but not
across height quartiles, where a direct association was apparent.
There were other differences in variables such as smoking or
hypertension but they did not follow a consistent pattern across
successive quartiles.
The relationship between quartiles of anthropometric indexes
and the risk of all-cause mortality is reflected in Table 2. We
observed that the hazard ratio tended to be highest in the top
quartiles for all anthropometric indexes.
For WHtR, the hazard ratios slightly and non-significantly
decreased in the second quartile and then increased in the upper
quartiles. Thus, the age- and sex-adjusted HRs (95% confidence
intervals) for categories of low, moderate, and high/very high
WHtR compared to the lowest (reference) category were 0.88
(0.64–1.20), 1.01 (0.75–1.37) and 1.39 (1.02–1.88), respectively
with a statistically significant linear trend (p = 0.027). In multivar-
iable-adjusted models, the HRs were 0.98 (0.72–1.35), 1.01 (0.74–
1.38), and 1.44 (1.05–1.97) for categories of low, moderate, and
high/very high WHtR, respectively, with a significant linear trend
(p = 0.026). Although the p for interaction with sex was not
statistically significant (p for interaction WHtR 6 sex = 0.34),
when we separated men and women, no significant association was
observed for men. But among women, a significant linear trend
remained apparent (p = 0.045 and p = 0.026 for age-adjusted, and
multivariable-adjusted models, respectively).
We observed that the hazard ratios for WC also increased across
succesive quartiles. The age- and sex-adjusted HRs (95%
confidence intervals) for quartiles of low, moderate, and high/
very high WC compared to the lowest quartile (ref.) were 1.01
(0.72–1.42), 1.17 (0.85–1.61) and 1.42 (1.03–1.96) respectively.
The linear trend was statistically significant (p = 0.020). After
multivariable adjustment, the HRs were 1.03 (0.73–1.46), 1.18
(0.86–1.63) and 1.36 (0.98–1.90) with a significant linear trend
(p = 0.046). Although the p for interaction with sex was not
statistically significant (p for interaction WC6 sex = 0.53), when
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Table 1. Baseline Characteristics of Participants according to categories of waist-to-height ratio, waist circumference, body mass
index and height.
Waist to height Ratio (WHtR)
Characteristic Lowest quartile N=1865 Quartiles 2–3 N=3734 Highest quartile N=1848
Waist-to-height ratio (mean 6 SD) 0.5560.03 0.6360.02 0.7160.04
Waist circumference – cm (mean 6 SD) 8967.3 10166.2 11168.2
Body mass index (mean 6 SD){ 26.462.5 29.962.8 33.763.3
Female sex – (%){ 51.3 53.8 71.2
Age-, – yr (mean 6 SD){ 66.066.1 67.066.2 67.966.1
Smoking – (%){
Never 56.8 58.5 71.3
Former smoker 25.6 26.8 19.4
Current 17.6 14.7 9.3
Overweight (BMI $25) – (%){ 75.4 97.4 99.9
Obesity (BMI $30) – (%){ 7.2 46.0 89.2
Hypertension – (%){ 77.4 83.3 87.1
Type-2 diabetes – (%){ 45.3 48.3 52.4
Dyslipidemia – (%) 73.4 71.8 72.2
Family history of premature CHD – (%){ 26.1 21.3 20.8
Leisure-time physical activity (METS min/d) (mean 6 SD){ 263.36252.6 242.26248.2 173.56193.4
Intervention group – (%){
MeDiet+EVOO 33.6 34.7 33.6
MeDiet+nuts 36.0 32.9 30.0
Control 30.4 32.4 36.4
MeDiet Adherence score (mean 6 SD){ 9.062.0 8.662.0 8.362.0
Waist Circumference (WC)
Characteristic Lowest quartileN=2029 Quartiles 2–3N=3661 Highest quartileN=1757
Waist circumference – cm (mean 6 SD) 8865.6 10163.6 11466.5
Waist-to-height ratio (mean 6 SD) 0.5660.44 0.6360.38 0.7060.54
Body mass index (mean 6 SD){ 27.062.9 29.963.0 33.463.5
Female sex – (%){ 75.3 53.5 45.4
Age-, – yr (mean 6 SD) 67.166.0 67.066.3 66.766.3
Smoking – (%){
Never 71.8 59.3 53.3
Former smoker 16.2 26.4 30.8
Current 12.1 14.3 15.9
Overweight (BMI $25) – (%){ 78.2 97.0 99.7
Obesity (BMI $30) – (%){ 14.0 46.4 86.3
Hypertension – (%){ 79.8 82.9 85.8
Type-2 diabetes – (%){ 43.7 49.3 52.4
Dyslipidemia – (%){ 75.7 72.0 68.9
Family history of premature CHD – (%){ 25.9 21.9 19.4
Leisure-time physical activity (METS min/d)
(mean 6 SD) (mean 6 SD){
230.36223.8 244.16249.9 201.46231.5
Intervention group – (%)
MeDiet+EVOO 34.8 34.2 33.4
MeDiet+nuts 33.9 32.9 31.9
Control 31.4 32.9 34.7
MeDiet Adherence score (mean 6 SD){ 8.962.0 8.662.1 8.462.0
Body Mass Index (BMI)
Characteristics ,25 kg/m2 N=563 .25 & ,30 kg/m2 N=3402 .30 kg/m2 N=3482
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Table 1. Cont.
Body Mass Index (BMI)
Characteristics ,25 kg/m2 N=563 .25 & ,30 kg/m2 N=3402 .30 kg/m2 N=3482
Body mass index (mean 6 SD) 23.561.2 27.761.4 33.262.7
Waist-to-height ratio (mean 6 SD){ 0.5460.05 0.6060.05 0.6760.06
Waist circumference – cm (mean 6 SD){ 8868.1 9668.2 10669.1
Female sex – (%){ 55.1 51.8 63.4
Age-, – yr (mean 6 SD) | 67.466.4 67.066.3 66.966.1
Smoking – (%){
Never 56.0 57.3 66.1
Former smoker 24.3 26.8 22.6
Current 19.7 16.0 11.3
Hypertension – (%){ 72.3 80.5 86.7
Type-2 diabetes – (%){ 64.5 46.2 48.2
Dyslipidemia – (%) 73.8 72.8 71.7
Family history of premature CHD – (%){ 30.9 21.4 22.0
Leisure-time physical activity (METS min/d)
(mean 6 SD) (mean 6 SD){
258.56265.5 260.66256.2 196.36211.7
Intervention group – (%)|
MeDiet+EVOO 34.6 33.9 34.3
MeDiet+nuts 36.2 34.2 31.2
Control 29.1 31.9 34.5
MeDiet Adherence score (mean 6 SD){ 8.862.0 8.862.0 8.462.0
Height
Characteristics according to height. Lowest quartile N=1960 Quartiles 2–3 N=3859 Highest quartile N=1628
Height – m (mean 6 SD) 1.4960.03 1.6060.04 1.7360.04
Waist-to-height ratio (mean 6 SD){ 0.6560.07 0.6360.06 0.6160.06
Waist circumference – cm (mean 6 SD){ 97610.3 100610.5 10569.7
Body mass index (mean 6 SD){ 30.864.1 29.963.8 29.263.4
Female sex – (%){ 97.1 59.5 5.0
Age-, – yr (mean 6 SD){ 66.965.9 67.066.0 64.966.5
Smoking – (%){
Never 87.9 62.1 27.3
Former smoker 7.5 24.1 46.8
Current 4.6 13.8 25.9
Overweight (BMI $25) – (%){ 95.1 91.9 90.9
Obesity (BMI $30) – (%){ 55.2 46.2 39.1
Hypertension – (%){ 86.2 82.6 78.9
Type-2 diabetes – (%){ 46.5 48.6 50.8
Dyslipidemia – (%)| 76.4 72.3 67.2
Family history of premature CHD – (%)| 24.4 22.4 19.9
Leisure-time physical activity (METS min/d)
(mean 6 SD) (mean 6 SD){
176.96171.6 231.76233.9 291.66299.4
Intervention group – (%)|
MeDiet+EVOO 33.8 34.3 34.3
MeDiet+nuts 30.3 33.3 32.4
Control 34.3 35.3 30.4
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Table 2. Hazard Ratios (95% confidence intervals) for total mortality according to quartiles of the waist-to-height ratio, waist
circumference, height and categories of body mass index.
Quartiles of waist-to-height ratio
HR according waist-to-height-ratio 1 (lowest) 2 3 4 (highest)
Limits 0.30 to 0.59 0.59 to 0.63 0.63 to 0.67 0.67 to 1.00
Number of deaths 83 75 89 101
Person-years 8188 8132 8059 7642 P for trend
Age-, sex-adjusted HR 1 (ref.) 0.88 (0.64–1.20) 1.01 (0.75–1.37) 1.39 (1.02–1.88) 0.027
Multivariable adjusted1 1 (ref.) 0.98 (0.72–1.35) 1.01 (0.74–1.38) 1.44 (1.05–1.97) 0.026
Men
Number of deaths 60 51 54 49
Person-years 3861 4022 3498 2185
Age-adjusted HR 1 (ref.) 0.80 (0.55–1.16) 0.85 (0.58–1.22) 1.28 (0.87–1.88) 0.344
Multivariable adjusted1 1 (ref.) 0.85 (0.58–1.24) 0.76 (0.52–1.12) 1.31 (0.87–1.97) 0.430
Women
Number of deaths 23 24 35 52
Person-years 4327 4110 4561 5457
Age-adjusted HR 1 (ref.) 1.07 (0.59–1.94) 1.42 (0.81–2.51) 1.65 (0.94–2.88) 0.045
Multivariable adjusted1 1 (ref.) 1.14 (0.63–2.05) 1.38 (0.78–2.45) 1.78 (1.02–3.11) 0.026
Quartiles of waist circumference
HR according waist circumference 1 (lowest) 2 3 4 (highest)
Limits 50 to 94 94.3 to 100 100.6 to 107 107.5 to 177
Number of deaths 75 70 97 106
Person-years 9107 7476 8168 7271 P for trend
Age-, sex-adjusted HR 1 (ref.) 1.01 (0.72–1.42) 1.17 (0.85–1.61) 1.42 (1.03–1.96) 0.020
Multivariable adjusted1 1 (ref.) 1.03 (0.73–1.46) 1.18 (0.86–1.63) 1.36 (0.98–1.90) 0.046
Men
Number of deaths 36 38 66 74
Person-years 2185 3158 4179 4045
Age-adjusted HR 1 (ref.) 0.73 (0.46–1.15) 0.92 (0.61–1.38) 1.07 (0.72–1.61) 0.323
Multivariable adjusted1 1 (ref.) 0.74 (0.47–1.19) 0.88 (0.58–1.34) 1.04 (0.67–1.61) 0.461
Women
Number of deaths 39 32 31 32
Person-years 6921 4318 3989 3226
Age-adjusted HR 1 (ref.) 1.42 (0.87–2.30) 1.43 (0.86–2.40) 1.88 (1.13–3.15) 0.018
Multivariable adjusted1 1 (ref.) 1.42 (0.87–2.30) 1.40 (0.84–2.34) 2.02 (1.21–3.38) 0.012
Quartiles of Body mass index
HR according body mass index 1 (lowest) 2 3 4 (highest)
Limits 17.78 to 27.22 27.23 to 29.73 29.74 to 32.45 32.46 to 52.97
Number of deaths 98 78 82 90
Person-years 9033 8002 8083 7902 P for trend
Age-, sex-adjusted HR 1 (ref.) 0.80 (0.60–1.08) 0.92 (0.68–1.24) 1.22 (0.91–1.65) 0.159
Multivariable adjusted1 1 (ref.) 0.80 (0.59–1.08) 0.84 (0.63–1.14) 1.14 (0.85–1.53) 0.371
Men
Number of deaths 67 55 48 44
Person-years 3756 3950 3567 2293
Age-, sex-adjusted HR 1 (ref.) 0.80 (0.56–1.14) 0.83 (0.57–1.20) 1.24 (0.85–1.83) 0.451
Multivariable adjusted1 1 (ref.) 0.72 (0.50–1.04) 0.67 (0.46–0.99) 1.05 (0.70–1.56) 0.858
Women
Number of deaths 31 23 34 46
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we separated men and women, the age-adjusted HRs were not
significant among men. Among women the age -adjusted HRs
were 1.42 (0.87–2.30), 1.43 (0.86–2.40) and 1.88 (1.13–3.15),
respectively. After multivariable-adjustment, these HRs were 1.42
(0.87–2.30), 1.40 (0.84–2.34) and 2.02 (1.21–3.38). The linear
trend among women was significant in both age-adjusted and
multivariable-adjusted models (p = 0.018 and 0.012 respectively).
For BMI the HRs increased across successive quartiles although
the results were not significant. The age- and sex-adjusted HRs
(95% confidence intervals) for quartiles of low, moderate, and
high/very high BMI compared to the lowest quartile (ref.) were
0.80 (0.60–1.08), 0.92 (0.68–1.24) and 1.22 (0.91– 1.65). After
multivariable adjustment, these HRs were 0.80 (0.59–1.08), 0.84
(0.63–1.14) and 1.14 (0.85–1.53). The linear trend was not
significant in any of both cases. The interaction with sex was not
significant (p = 0.77). When we separated men and women, no
significant association was observed for either category although
among women the association was stronger.
When we classified the sample according to quartiles of height
we also observed increased hazard ratios across successive
quartiles. The p for interaction with sex was not significant
(p = 0.35). When we studied each sex separately we observed that
the HRs increased in both cases across successive quartiles.
However among men this increase was higher, although in both
cases, after multivariable adjustment, we observed no significant
association between height and total mortality.
We conducted similar analyses using a priori defined cut-off
points instead of quartiles. We observed in Table 3 that hazard
ratios tended to be highest in the upper categories of the
anthropometric indexes, in the same way as we observed in
Table 2. We observed also that the hazard ratio decreased in the
second category and then it increased in the upper categories.
When we analyzed separately each anthropometric index, we
found this same trend. In the case of WHtR (cut-off points: 0.60,
0.65, 0.70) we observed that the hazard ratio monotonically
increased. The age and sex-adjusted Hazard ratios (95%
confidence intervals) for each category were 1.01 (0.77–1.32),
1.28 (0.96–1.71), and 1.58 (1.11–2.26), for WHtR categories of
0.60–0.65, 0.65–0.70 and .0.70 with respect to ,0.65, with a
significant direct linear trend (p = 0.009). After multivariable
adjustment, these HRs were 1.02 (0.78–1.34), 1.30 (0.97–1.75)
and 1.55 (1.06–2.26), respectively with a significant linear trend
(p = 0.013). Although the p for interaction with sex was not
significant (p = 0.45), when we separated men and women, we
observed no significant associations among men after multivari-
able adjustment. However among women, the multivariable-
adjusted HRs for successive categories were 1.34 (0.81–2.22), 1.82
(1.09–3.06) and 1.84 (1.03–3.29). The linear trend among women
was significant in both age-adjusted and multivariable-adjusted
Table 2. Cont.
Quartiles of Body mass index
HR according body mass index 1 (lowest) 2 3 4 (highest)
Person-years 4277 4052 4516 5609
Age-adjusted HR 1 (ref.) 0.80 (0.47–1.36) 1.06 (0.64–1.73) 1.22 (0.77–1.95) 0.245
Multivariable adjusted1 1 (ref.) 0.79 (0.45–1.40) 1.04 (0.64–1.69) 1.22 (0.74–2.00) 0.264
Quartiles of height
HR according height 1 (lowest) 2 3 4 (highest)
Limits (cm) 135 to 153 154 to 159 160 to 167 168 to 191
Number of deaths 70 64 109 105
Person-years 8518 7746 8947 6810 P for trend
Age-, sex-adjusted HR 1 (ref.) 0.99 (0.70–1.41) 1.12 (0.75–1.65) 1.32 (0.86–2.04) 0.096
Multivariable adjusted1 1 (ref.) 0.99 (0.70–1.41) 1.05 (0.71–1.54) 1.18 (0.76–1.83) 0.380
Men
Limits (cm) 142 to 163 164 to 167 168 to 172 173 to 191
Number of deaths 61 49 56 48
Person-years 3883 3185 3711 2787
Age-adjusted HR 1 (ref.) 1.14 (0.79–1.66) 1.16 (0.81–1.66) 1.52 (1.04–2.22) 0.046
Multivariable adjusted1 1 (ref.) 1.06 (0.73–1.53) 1.03 (0.72–1.48) 1.35 (0.91–2.02) 0.213
Women
Limits (cm) 135 to 150 151 to 154 155 to 159 160 to 178
Number of deaths 39 33 38 24
Person-years 4767 4797 5213 3678
Age-adjusted HR 1 (ref.) 0.95 (0.60–1.52) 1.13 (0.71–1.79) 1.20 (0.71–2.06) 0.430
Multivariable adjusted1 1 (ref.) 0.83 (0.52–1.34) 1.02 (0.64–1.65) 1.03 (0.59–1.81) 0.790
The PREDIMED study 2003–2010.
1Adjusted for age, (sex, when pertinent) smoking, diabetes status, hypertensive status, intervention group and family history of CHD.
All estimates are stratified for study center. The interaction term between age and each antropometric index was not statistically significant in all analyses: p = 0.34 (for
waist-to- height ratio); p = 0.53 (for waist circumference); p = 0.35 (for height) and p = 0.77 (for body mass index).
doi:10.1371/journal.pone.0103246.t002
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Table 3. Hazard Ratios (95% confidence intervals) for total mortality according to categories (a priori defined cut-off points) of the
waist-to-height ratio and waist circumference.
Waist-to-height ratio
Limits ,= 0.60 .0.60 to 0.65 .0.65 to 0.70 .0.70
Number of deaths 104 106 87 51
Person-years 10841 10485 6921 3774 P for trend
Age-, sex-adjusted HR 1 (ref.) 1.01 (0.77–1.32) 1.28 (0.96–1.71) 1.58 (1.11–2.26) 0.009
Multivariable adjusted1 1 (ref.) 1.02 (0.78–1.34) 1.30 (0.97–1.75) 1.55 (1.06–2.26) 0.013
Men
Number of deaths 75 69 46 24
Person-years 5230 4887 2613 837
Age-adjusted HR 1 (ref.) 0.91 (0.66–1.25) 1.08 (0.74–1.56) 1.62 (1.01–2.62) 0.148
Multivariable adjusted1 1 (ref.) 0.82 (0.59–1.13) 1.01 (0.69–1.49) 1.59 (0.94–2.67) 0.238
Women
Number of deaths 29 37 41 27
Person-years 5611 5598 4308 2937
Age-adjusted HR 1 (ref.) 1.29 (0.78–2.13) 1.70 (1.02–2.83) 1.67 (0.94–2.97) 0.036
Multivariable adjusted1 1 (ref.) 1.34 (0.81–2.22) 1.82 (1.09–3.06) 1.84 (1.03–3.29) 0.016
Waist circumference
Limits (cm) ,=100 .100 to 105 .105 to 110 .110
Number of deaths 119 72 57 100
Person-years 13000 6632 5651 6737 P for trend
Age-adjusted HR 1(ref.) 1.14 (0.85–1.53) 1.04 (0.76–1.43) 1.69 (1.29–2.23) 0.002
Multivariable adjusted1 1(ref.) 1.18 (0.88–1.59) 1.02 (0.74–1.41) 1.57 (1.19–2.08) 0.008
Men
Limits ,=100 .100 to 105 .105 to 110 .110
Number of deaths 68 45 36 65
Person-years 4721 3108 2642 3096
Age-adjusted HR 1 (ref.) 1.01 (0.69–1.46) 0.89 (0.59–1.33) 1.43 (1.01–2.02) 0.093
Multivariable adjusted1 1 (ref.) 0.98 (0.67–1.42) 0.87 (0.58–1.31) 1.32 (0.92–1.90) 0.204
Women
Limits ,=95 .95 to 100 .100 to 105 .105
Number of deaths 40 28 18 48
Person-years 6982 3558 3285 4630
Age-adjusted HR 1 (ref.) 1.45 (0.88–2.39) 0.99 (0.55–1.80) 1.93 (1.21–3.07) 0.012
Multivariable adjusted1 1 (ref.) 1.40 (0.85–2.31) 1.08 (0.60–1.94) 1.93 (1.21–3.07) 0.012
Height
Limits (cm) ,=165 .165 to 170 .170 to 175 .175
Number of deaths 175 90 52 31
Person-years 16303 8849 4854 2014 P for trend
Age-, sex-adjusted HR 1 (ref.) 0.99 (0.77–1.28) 1.10 (0.80–1.52) 1.57 (1.07–2.31) 0.038
Multivariable adjusted1 1 (ref.) 0.95 (0.73–1.23) 1.05 (0.77–1.45) 1.42 (0.97–2.08) 0.247
Men
Limits (cm) ,=165 .165 to 170 .170 to1.75 .175
Number of deaths 91 56 39 28
Person-years 5510 4012 2762 1282
Age-adjusted HR 1 (ref.) 0.96 (0.69–1.34) 1.11 (0.76–1.62) 1.73 (1.13–2.63) 0.046
Multivariable adjusted1 1 (ref.) 0.89 (0.64–1.25) 1.03 (0.70–1.52) 1.57 (0.99–2.51) 0.213
Women
Limits (cm) .155 .155 to 160 .160 to 1.65 .165
Number of deaths 84 34 13 3
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models (p = 0.036 and 0.016, respectively). This trend was also
apparent in the spline analysis (Figure 1).
In the case of WC (cut-off points: 100, 105 and 110 cm) we
observed that the hazard ratios increased across successively
increasing categories with the exception of one of the intermediate
groups (105 to 110 cm). The age-, and sex-adjusted HRs (95%
confidence intervals) were 1.14 (0.85–1.53), 1.04 (0.76–1.43) and
1.69 (1.29–2.23) with a significant linear trend (p = 0.002). After
multivariable adjustment, these HRs were 1.18 (0.88–1.59), 1.02
(0.74–1.41) and 1.57 (1.19–2.08) with a significant linear trend
(p = 0.008). The p for interaction with sex was not significant
(p = 0.73). When we divided the sample into men and women, no
significant association was observed after multivariable adjustment
among men. But the association remained apparent among
women (cut-off points: 95,100, 105), with multivariable-adjusted
HRs of 1.40 (0.85–2.31), 1.08 (0.60–1.94) and 1.93 (1.21–3.07),
with a significant linear trend (p = 0.012).
The risk of total mortality across the different categories of BMI
(,25, 25–30, 30–35, .35) is shown in the Table 4. We observed
that the Hazard ratios decreased in the second group and then
they increased in the upper categories. This trend was also
apparent in the spline analysis (Figure 2). The p for interaction
with sex was not significant (p = 0.43). The adjusted HRs obtained
were not significant in men nor women when we stratified the
sample by sex. We repeated these analyses after excluding deaths
in the first follow-up year and also after excluding ever smokers. In
Table 3. Cont.
Height
Person-years 10793 4837 2092 732
Age-adjusted HR 1 (ref.) 1.07 (0.71–1.60) 1.11 (0.61–2.01) 0.97 (0.29–3.22) 0.430
Multivariable adjusted1 1 (ref.) 1.06 (0.69–1.61) 0.97 (0.51–1.87) 1.04 (0.33–3.26) 0.790
The PREDIMED study 2003–2010.
1Adjusted for age, smoking, diabetes status, hypertensive status, intervention group and family history of CHD.
All estimates are stratified for study center. The interaction term was not statistically significant in case of waist-to-height ratio (p = 0.45).
When the analyses were restricted to deaths occurring after .= 2 yr follow-up, the only noticeable change was for the category .0.65 to 0.70 which exhibited a higher
and significant elevated risk of death in the overall sample (multivariable-adjusted HR = 1.43, 95% CI: 1.03–1.97 in the total sample; 1.14 (0.77–2.42) in men, and 1.88
(1.09–3.24) in women).
doi:10.1371/journal.pone.0103246.t003
Figure 1. Relative risk of death according to Waist-to-height ratio. Restricted cubic spline model adjusted for age, smoking, diabetes status,
hypertensive status, intervention group and family history of CHD.
doi:10.1371/journal.pone.0103246.g001
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these analyses we found slightly stronger direct associations
between BMI and risk of death.
When we assessed height, we found increased risk of death in
the taller groups with the exception of the second group for men
where the HR decreased. The age-sex-adjusted HRs (95%
confidence intervals) for each group (cut-off points: 1.65, 1.70,
1.75 cm) were 0.99 (0.77–1.28), 1.10 (0.80–1.52) and 1.57 (1.07–
2.31). The linear trend was significant (p = 0.038). But after
multivariable adjustment the HRs were not significant. Although
the p for interaction was not significant (p = 0.33), when we
separated men and women, the age-adjusted HRs were not
significant for women (cut-off points: 1.55, 1.60, 1.65). Among
men the age -adjusted HRs were 0.96 (0.69–1.34), 1.11 (0.76–1.62)
and 1.73 (1.13–2.63), respectively, with a significant linear trend
(p = 0.046). However, after multivariable adjustment this associa-
tion became non-significant.
Almost fifty percent of our participants were diabetics. We
investigated the relationship between WHtR and risk of death
within the group of diabetic participants (table 5). We found a
significant direct linear trend after multivariable adjustment in the
diabetic group (p = 0.031). However no statistically significant
interaction with diabetes was found (p = 0.85).
We also studied the relationship between the WHtR index and
the risk of all-cause mortality separating the sample according to
the randomly allocated group of dietary intervention (arm of the
trial) in the Predimed trial: MeDiet with EVOO, MeDiet with
nuts, and control diet (Table 6). We found a consistent direct
association between WHtR and overall mortality within each of
the three intervention arms of the trial. However, the p value for
interaction was close to statistical significance (p = 0.056). A
significant linear trend after multivariable adjustment suggesting a
direct, dose-response relationship between baseline WHtR and
mortality was apparent only within the group allocated to a
MeDiet with nuts (p = 0.034). In any case, we did not find evidence
to support that the PREDIMED intervention was able to
counterbalance the harmful effects of increased adiposity on total
mortality. Reassuringly, no significant increase in total mortality
associated with the active intervention was apparent within the
subgroup of participants with the highest levels of WHtR (p = 0.72
for MeDiet + EVOO and p = 0.64 for MeDiet + mixed nuts).
We fitted restricted cubic spline models to show graphically the
relationship between the WHtR (Figure 1) or BMI (Figure 2) and
relative risk of death. In figure 1 we present the dose-response
relationship between WHtR and total mortality. We found the
highest risk of death in participants with the highest levels of
abdominal obesity, as measured by the WHtR, and the lowest risk
for a WHtR = 0.6. When we assessed the shape of the dose-
response association between BMI and total mortality (Figure 2),
we observed that the risk of death was highest for the lowest
category of BMI, then it decreased to the lowest risk for values of
BMI = 28 kg/m2, and then it tended to increase again for upper
values of BMI. The comparison of both trends suggested that the
upper levels of WHtR are associated with a higher risk of death
than the upper levels of BMI.
Figure 2. Relative risk of death according to BMI. Restricted cubic spline model adjusted for age, smoking, diabetes status, hypertensive status,
intervention group and family history of CHD.
doi:10.1371/journal.pone.0103246.g002
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Table 4. Hazard Ratios (95% confidence intervals) for total mortality according to categories of body mass index.
Normal Overweight Grade I obesity Grade II obesity
Limits (kg/m2) ,=25 .25 to 30 .30 to 35 .35
Number of deaths 37 148 135 27
Person-years 2493 14591 12233 2701 P for trend
Age-, sex-adjusted HR 1 (ref.) 0.74 (0.51–1.06) 0.91 (0.63–1.31) 1.06 (0.63–1.78) 0.323
Multivariable adjusted1 1 (ref.) 0.84 (0.58–1.21) 0.95 (0.66–1.37) 1.13 (0.66–1.92) 0.387
Excluding deaths in the 2 first follow-up years 1 (ref.) 1.02 (0.66–1.59) 1.15 (0.74–1.78) 1.33 (0.69–2.56) 0.227
Excluding also ever smokers 1 (ref.) 1.39 (0.68–2.83) 1.56 (0.76–3.17) 1.76 (0.70–4.42) 0.175
Men
Number of deaths 26 102 74 11
Person-years 1092 7096 4816 560
Age-adjusted HR 1 (ref.) 0.68 (0.44–1.04) 0.77 (0.49–1.21) 1.18 (0.57–2.47) 0.767
Multivariable adjusted1 1 (ref.) 0.70 (0.45–1.10) 0.71 (0.45–1.12) 1.48 (0.69–3.19) 0.915
Excluding deaths in the 2 first follow-up years 1 (ref.) 0.86 (0.50–1.49) 0.83 (0.47–1.46) 1.45 (0.50–4.24) 0.958
Women
Number of deaths 11 46 61 16
Person-years 1402 7494 7417 2141
Age-adjusted HR 1 (ref.) 0.83 (0.43–1.59) 1.11 (0.58–2.12) 1.12 (0.50–2.49) 0.277
Multivariable adjusted1 1 (ref.) 1.08 (0.52–2.21) 1.40 (0.70–2.82) 1.36 (0.57–3.25) 0.199
Excluding deaths in the 2 first follow-up years 1 (ref.) 1.30 (0.54–3.12) 1.72 (0.75–3.98) 1.91 (0.68–5.33) 0.079
The PREDIMED study 2003–2010.
1Adjusted for age, smoking, diabetes status, hypertensive status, intervention group and family history of CHD.
All estimates are stratified for study center.
doi:10.1371/journal.pone.0103246.t004
Table 5. Hazard Ratios (95% confidence intervals) for total mortality according to quartiles of the waist-to-height ratio within
diabetics or no diabetics persons.
1 (lowest) 2 3 4 (highest)
Limits 0.30 to 0.59 0.59 to 0.63 0.63 to 0.67 0.67 to 1.00
Number of deaths 83 75 89 101
Person-years 8188 8132 8059 7642 P for trend
Age-, sex-adjusted HR 1 (ref.) 0.88 (0.64–1.20) 1.01 (0.75–1.37) 1.39 (1.02–1.88) 0.027
Multivariable adjusted1 1 (ref.) 0.98 (0.72–1.35) 1.01 (0.74–1.38) 1.44(1.05–1.97) 0.026
No diabetes
Number of deaths 36 31 31 32
Person-years 4407 4282 3899 3567
Age-adjusted HR 1 (ref.) 0.78 (0.49–1.26) 0.86 (0.53–1.40) 1.16 (0.70–1.91) 0.587
Multivariable adjusted1 1 (ref.) 0.92 (0.56–1.52) 0.95 (0.57–1.59) 1.24 (0.73–2.09) 0.471
Diabetes
Number of deaths 47 44 58 69
Person-years 3781 3850 4160 4075
Age-adjusted HR 1 (ref.) 0.96 (0.63–1.45) 1.10 (0.75–1.63) 1.53 (1.04–2.25) 0.021
Multivariable adjusted1 1 (ref.) 1.00 (0.66–1.51) 1.04 (0.71–1.54) 1.54 (1.03–2.29) 0.031
The PREDIMED study 2003–2010.
Adjusted for age, sex, smoking, and family history of CHD.
All estimates are stratified for study center. The interaction term was not statistically significant (p = 0.85).
doi:10.1371/journal.pone.0103246.t005
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Discussion
In this trial of 7447 elderly participants at high cardiovascular
risk but initially free of cardiovascular disease, we observed a direct
relationship between some adiposity measurements (WC, WHtR,
BMI, height) and all cause mortality after 4.8 years of follow-up.
However, this relationship was not significant for men and it was
not linear in most cases.
A high biological plausibility exists to expect a direct association
between excess body weight and all-cause mortality. However, we
did not observe any linear trend for body mass index and a
curvilinear shaped dose-response association was apparent for
indexes of abdominal obesity. Importantly, we observed a lower
risk in persons who had moderate levels of overweight compared
with normal persons. Thereby, the risk of mortality was sometimes
higher for the lowest category of adiposity indexes, specially for
BMI, then it decreased and finally it increased again in the upper
categories of each anthropometric index. This was in parcial
agreement with the results of a recent meta-analysis on BMI and
total mortality which concluded that overweight ([BMI] of 25 to
30 kg/m2) was associated with significantly lower all-cause
mortality in comparison with the normal weight category and
that grade I obesity (BMI between 30 and 35) was associated with
a non-significantly lower risk of mortality [1]. Other previous
metaanalyses also suggested inverse or null associations, specially
among elderly subjects. [2,3]. In any case, methodological aspects
deserve caution in the interpretation of some studies included in
these meta-analyses. A potential cause of concern is reverse
causation bias due to pre-existent disease [24]. In addition, BMI
may not be the most appropriate anthropometric index to assess
the risks of adiposity.
However, a recent meta-analysis [25] concluded that the
existence of a ‘‘healthy’’ pattern of increased weight is not likely
to be tenable. On the contrary, any increase in adiposity is
associated with increases in levels of cardiovascular risk factors and
also in cardiovascular events that will, very probably, lead to
increases in total mortality. Excess weight is associated with
subclinical metabolic and vascular dysfunction that with the
passage of time leads to an increased risk of CV events and
mortality. Nevertheless, normal weight persons could have high
risk for having metabolic abnormalities as it has been reported
recently by De Larochellie`re et al. [13]. In this context, the routine
measurement of WC and the use of WHtR.0.6 as a criterion for
excess adiposity would improve the identification of higher-risk
subjects. These individuals with normal weight nd increased levels
of abdominal obesity could be genetically predisposed to CV
disease and could have events even without experiencing increases
in body weight or general adiposity. Therefore, it is necessary to
consider not only body weight but also metabolic abnormalities. In
this context, the use of WC or WHtR should be recommended,
instead of using only the BMI.
In this line of thought, one of our contributions in the present
work was the use of different indexes of adiposity, and not only
BMI. Many previous studies have also used WC. But the use of the
WHtR is still scarce. BMI has been widely used by the scientific
community to assess obesity. However, BMI cannot distinguish
between the accumulation of lean or fat mass, it cannot assess the
distribution of fat and the change of this distribution with age nor
take into account the changes that occurs in people who begin a
diet accompanied or not by exercise.
Interestingly, we found that WC presented a stronger associ-
ation with mortality than BMI, observing significant results,
specially among women. This finding was consistent with other
studies [26,27] showing stronger correlations with visceral fat for
WC than for BMI, particulary among elderly participants such as
those included in our study.
Recent studies [26, 28–30] suggest that WHtR is likely to be the
best anthropometric index to assess the association of adiposity
Table 6. Hazard Ratios (95% confidence intervals) for total mortality according to quartiles of the waist-to-height ratio within each
of the three intervention groups.
1 (lowest) 2 3 4 (highest)
Limits 0.30 to 0.59 0.59 to 0.63 0.63 to 0.67 0.67 to 1.00
Med Diet with Nuts
Number of deaths 26 27 33 30 p for trend
Person-years 2890 2638 2573 2287
Age-, sex-adjusted HR 1 (ref.) 1.11 (0.65–1.90) 1.47 (0.89–2.44) 1.65 (0.95–2.88) 0.048
Multivariable adjusted1 1 (ref.) 1.19 (0.69–2.07) 1.53 (0.91–2.57) 1.76 (0.99–3.11) 0.034
Med Diet with EVOO
Number of deaths 32 27 21 38
Person-years 2948 3054 3061 2792
Age-, sex-adjusted HR 1 (ref.) 0.80 (0.47–1.34) 0.56 (0.32–0.98) 1.26 (0.78–2.04) 0.507
Multivariable adjusted1 1 (ref.) 0.86 (0.50–1.46) 0.54 (0.30–0.98) 1.25 (0.75–2.08) 0.581
Control Diet
Number of deaths 25 21 35 33
Person-years 2351 2440 2425 2562
Age-, sex-adjusted HR 1 (ref.) 0.79 (0.43–1.43) 1.23 (0.72–2.09) 1.27 (0.73–2.01) 0.231
Multivariable adjusted1 1 (ref.) 0.80 (0.44–1.45) 1.24 (0.73–2.12) 1.21 (0.68–2.14) 0.311
The PREDIMED study 2003–2010.
1Adjusted for age, sex, smoking, and family history of CHD.
All estimates are stratified for study center. The interaction term was not statistically significant (p = 0.056).
doi:10.1371/journal.pone.0103246.t006
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with cardiovascular risk or overall mortality. This is partially in
line with our investigation in which we observed in the restricted
cubic spline models that the highest risk of mortality were present
in participants from the upper categories of WHtR in contrast with
the dose-response trend observed for BMI in which the increased
risk of death was less attenuated and the highest relative risk was
observed for the leanest subjects. Therefore this is one of the main
contributions of our investigation, because we used this anthopo-
metric index (WHtR) and almost no previous studies have
longitudinally related this parameter to the risk of death in elderly
subjects. In our study we observed that WHtR and WC were the
best measures of obesity because using both indexes we obtained
significant direct associations, specially for WC. However, WC
might underestimate the relative amount of abdominal fat in short
persons and overestimate it in tall persons [9–11,15]. This was the
reason why we also assessed the role of height. Taking into account
that height showed also some associations with mortality, and can
introduce confounding in the assessment of the association
between WC and mortality, and that the results for WC and
WHtR were similar, we consider that WHtR may be preferable
and can be used when evaluating CVD mortality risk.
The association between the WHtR and overall mortality was
slightly stronger among diabetics. Our study is unique in terms of
the large percentage of diabetics (almost fifty percent) of our
cohort. However the statistical interaction with diabetes was not
significant and further studies on this issue are needed.
Our sample was composed of elderly subjects at high risk of
cardiovascular disease, for whom being underweight has been also
identified as a predictor of diabetes [31]. However, the precise
mechanisms behind the association between low BMI (under-
weight) and diabetes among the elderly are not yet clarified. A
possible explanation could be that protein-calorie malnutrition
and magnesium deficiency may cause low insulin secretion and a
low pancreatic insuline store. A recent study showed that low
dietary magnesium and low mean serum albumin levels were
associated with higher risk of type 2 diabetes [32].
However, it is true that abdominal adipose tissue can play an
important role in the development of diabetes mellitus and it can
also increase the risk of death [33,34].
Interestingly, after taking into account the dietary intervention
conducted in PREDIMED trial, we did not obtain a significant
interaction. Therefore we cannot provide evidence that our
dietary intervention was able to counterbalance the higher
mortality risk associated with higher levels of adiposity. However,
in the main results of the PREDIMED trial [17], we found strong
evidence for the prevention of major cardiovascular events, but
not for total mortality, using a MeDiet supplemented with either
extra-virgin olive oil or mixed nuts. A posible explanation could be
that when total mortality is used as outcome, we consider all causes
of mortality not only cardiovascular causes and there are other
important causes of mortality (such as cancer or respiratory causes)
where subclinical disease is associated with weight loss. Another
aspect to be considered is that in the PREDIMED trial the average
WC of participants was greater than 100 cm and the average BMI
was greater than 30 kg/m2. In addition, these participants were at
high cardiovascular risk because they had other cardiovascular risk
factors and fifty percent of them were type-2 diabetics. Neverthe-
less the protocol of the PREDIMED intervention did not include
specific caloric restriction or targeted goals for weight loss. In this
context, and given the present results, a trial using an energy-
restricted MeDiet would be likely to obtain even greater
cardiovascular benefits. The new on-going trial referred to as
PREDIMEDPLUS (www.predimedplus.com) will assess the effect
of this combined intervention on major cardiovascular events and
total mortality.
There are several strengths in our research. The prospective
nature of our study with a long follow-up period allowed us to
detect a sufficient number of deaths. In addition we were able to
control for multiple potential confounders using multiple-adjusted
models. The results could suggest causal associations because in
Cox regression we controlled for a high number of potential
confounders. However, residual confounding by unmeasured
factors is always a possibility in observational research.
In contrast, the older age of our participants together with their
high cardiovascular risk could contribute to modify the association
between adiposity measures and all-cause mortality. Obesity has
been associated with improved survival in patients with existing
chronic diseases, including chronic obstructive pulmonary disease,
chronic kidney disease, or heart failure. This fact has been termed
the ‘‘obesity paradox’’ [24,35]. This paradox may attenuate the
detrimental effects of adiposity on mortality. In addition, total
body mass increases across the life span until about age 60 and
then it tends to decrease due to the process of sarcopenia which
involves a decrease in muscle mass and on the other hand a
smaller increase in fat mass. Moreover, at that age a fat re-
distribution occurs, and, as a result of this re-distribution, the fat
that was out of the trunk tend to be displaced to abdominal areas,
thus increasing the metabolic risk [36]. Previous studies have
suggested that BMI do not capture the increase in abdominal
adipose tissue that tends to occur with age and this could explain
the weakened association between BMI and risk of death that is
usually observed with age [29]. All these reasons support the
preferential use of the WHtR in elderly subjects.
Previous studies suggested a weak relationship of WC and BMI
with cardiovascular risk in older adults [3,37,38]. Stevens et al. [7]
described that the relative risk of all-cause and cardiovascular
mortality associated with an excess body mass is greater for
younger and middle-aged individuals than for older individuals.
However, this effect modification by age has been recently
challenged because the reduction in the magnitude of the
association obesity–mortality with age maybe confounded by age
at survey and cohort effects [39].
For these reasons, the present research gained more impor-
tance. Notwithstanding that in our study all participants were
elderly subjects, we found a significant direct relationship between
some adiposity measures (specially WC and WHtR) and all-cause
mortality. But as in other studies, we found a weaker relationship
for BMI than for these other measures.
A possible explanation for the non-significant relationships or
the weaker associations found among men than among women, is
the well-known longer survival of women. There could be a
selective survival effect of healthier, older men because the
unhealthy men with higher levels of adiposity at high cardiovas-
cular risk may have already died from the detrimental effects of
obesity. In addition, older individuals tend to decrease their intake
of food and may not consume energy-rich diets that are related to
a higher risk of death.
In conclusion, our study showed a direct association between
adiposity measures reflecting visceral accumulation of fat (WC,
WHtR) and all-cause mortality in an elderly population at high
cardiovascular risk. The highest risk of death was observed in
participants who initally were in the highest quartiles of these
anthropometric indexes (WC, WHtR) that better capture abdom-
inal obesity. For BMI, instead, we observed an U-shaped dose-
response pattern, with the highest mortality in participants with
the initial lowest values of BMI. However, further research is
Obesity Indexes and Mortality among Elderly Subjects at PREDIMED Study
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warranted to confirm these findings and to extend our findings to
other elderly populations with a lower cardiovascular risk.
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